Loading insider details...
Beta
Latest Form 4 (Jul 23, 2026): Grant/Award of 380 UTHR shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 23, 2026 | UNITED THERAPEUTICS Corp (UTHR) | Grant/Award | 380 | n/a |
| Jun 11, 2026 | ImmunityBio, Inc. (IBRX) | Grant/Award | 65,600 | n/a |
| Jul 28, 2025 | UNITED THERAPEUTICS Corp (UTHR) | Grant/Award | 3,650 | n/a |
| Jun 20, 2025 | ImmunityBio, Inc. (IBRX) | Grant/Award | 162,786 | n/a |
| Jul 26, 2024 | UNITED THERAPEUTICS Corp (UTHR) | Grant/Award | 2,890 | n/a |
| Jun 13, 2024 | ImmunityBio, Inc. (IBRX) | Grant/Award | 77,633 | n/a |
| Jul 17, 2023 | UNITED THERAPEUTICS Corp (UTHR) | Grant/Award | 4,560 | n/a |
| Jun 15, 2023 | ImmunityBio, Inc. (IBRX) | Grant/Award | 158,263 | n/a |
| Jul 8, 2022 | UNITED THERAPEUTICS Corp (UTHR) | Grant/Award | 4,980 | n/a |
| Jun 15, 2022 | ImmunityBio, Inc. (IBRX) | Grant/Award | 167,937 | n/a |